EDITAS MEDICINE, INC. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
EDITAS MEDICINE, INC. (EDIT) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $1.09 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2019-11-12
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $1.09M.
- 2019-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $2.29M.
- 2019-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $3.66M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $1.09M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.29M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.66M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |